In a recent study, Dr. Aseem Malhotra, a leading British cardiologist and previously a proponent for the COVID-19 mRNA vaccines, declared the global pandemic a pandemic of misinformation and called for a global stop of COVID-19 vaccinations. “What has become clear with regard to the coronavirus disease 2019 (COVID-19) vaccines is that we have a…
Institutional Corruption and a Pandemic of Misinformation: Previous Proponent for COVID-19 Jabs Calls for Global Stop
ALS Drug Wins FDA Approval Despite Questionable Data
WASHINGTON—A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines. The Food and Drug Administration approved the drug from Amylyx Pharmaceuticals based on results from one small, mid-stage study in which patients with…
LIVE NOW: Biden Admin Makes Reversal on Student Loan Forgiveness; Hurricane Ian Leaves Trail of Destruction | NTD News Today
In other news, The Biden administration quietly issues an update to its student loan forgiveness plan. It’s scaling back eligibility, as six states say the program is illegal. The FDA, withholding autopsy results of people who died after getting COVID-19 vaccines. The agency says they can’t give it out, but not everyone agrees. The Biden…
Biden Admin Makes Reversal on Student Loan Forgiveness; Hurricane Ian Leaves Trail of Destruction | NTD News Today
In other news, The Biden administration quietly issues an update to its student loan forgiveness plan. It’s scaling back eligibility, as six states say the program is illegal. The FDA, withholding autopsy results of people who died after getting COVID-19 vaccines. The agency says they can’t give it out, but not everyone agrees. The Biden…
FDA Issues New Safety Warning on Rare Cancers Linked to Breast Implants
The U.S. Food and Drug Administration (FDA) has issued a new warning about rare cases of certain cancers, including squamous cell carcinoma (SCC) and various lymphomas, linked to breast implants. In a safety communication notice posted on Sept. 8, the FDA said it had received reports of cancers found in the scar tissue, or capsule, that forms around…
FDA Warns of Cybersecurity Risk With Certain Medtronic Insulin Pumps
The U.S. Food and Drug Administration on Tuesday warned that certain types of insulin pump systems manufactured by Medtronic were vulnerable to cyberattacks and that hackers could potentially hamper insulin delivery by accessing the device. The agency issued a cybersecurity risk alert for the Medtronic MiniMed 600 Series insulin pump system, which has several components…
Juul Sues FDA After Agency Declines to Hand Over Documents Supporting E-Cigarette Ban
Electronic-cigarette maker Juul has filed a lawsuit against the Food and Drug Administration (FDA) after the agency earlier this year ordered the company to remove its products from stores in the United States. The lawsuit (pdf) was filed on Sept. 20 in a court in Washington, D.C., over the agency’s refusal to hand over supporting…
Multiple Factors Hindered FDA’s Response to Infant Baby Formula Shortage: Internal Review
An internal review published by the U.S. Food and Drug Administration (FDA) on Tuesday found that multiple factors hindered the agency’s response this year to the nationwide shortage of baby formula. Steven Solomon, the head of the FDA’s veterinary division who conducted the internal review, said he found five “major areas of need” and 15 specific…
FDA Approves Bluebird Bio’s Gene Therapy for a Rare Neurological Disorder
The U.S. Food and Drug Administration (FDA) has approved Bluebird bio’s gene therapy for the treatment of a rare neurological disorder, the company said late on Friday. “SKYSONA is the first FDA approved therapy shown to slow the progression of neurologic dysfunction in boys” with early, active Cerebral Adrenoleukodystrophy (CALD), the company said in a…
FDA to Review Perrigo’s Birth Control Pill for Over-the-Counter Use
Perrigo Co. Plc. said on Monday that the U.S. Food and Drug Administration (FDA) has scheduled a meeting of external experts on Nov. 18 to review the application of its daily birth control pill for over-the-counter (OTC) use. Contraception access has taken the spotlight since the U.S. Supreme Court’s decision in June to overturn the…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`